arrow-left  #dr-reddy's

Image not found
     
  • 01 March, 2024 |
  •  
  • 4:28 PM

The complaint alleges Dr Reddy's "improperly restrained competition" and maintained a monopoly for the cancer drug Revlimid.

Read More

More News

ALL #dr-reddy's
Image not found
  • The complaint alleges Dr Reddy's "improperly restrained competition" and maintained a monopoly for the cancer drug Revlimid.
  • |
  • IIFL News Service |
  • 01 March, 2024 |
  • 12:18 AM
Image not found
  • This strategic move aligns with the company's vision for expansion and consolidation in the pharmaceutical sector.
  • |
  • IIFL News Service |
  • 19 February, 2024 |
  • 12:02 AM
Image not found
  • Recommendation: Add; Target price: ₹2515
  • |
  • IIFL News Service |
  • 14 February, 2024 |
  • 11:54 PM
Image not found
  • Keeping in view the current global scenario, India presents an exciting opportunity.
  • |
  • IIFL News Service |
  • 14 February, 2024 |
  • 11:54 PM
ad IconAd Image